We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

72 hedge funds and large institutions have $307M invested in Collegium Pharmaceutical in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 38 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 16

31% more capital invested

Capital invested by funds: $235M → $307M (+$72.2M)

4.03% more ownership

Funds ownership: 79.3% → 83.33% (+4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less funds holding

Funds holding: 83 → 72 (-11)

56% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 16

72% less call options, than puts

Call options by funds: $149K | Put options by funds: $529K

Holders
72
Holders Change
-11
Holders Change %
-13.25%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
38
Reduced
16
Closed
16
Calls
$149K
Puts
$529K
Net Calls
-$380K
Net Calls Change
-$639K

Top Buyers

Rank Fund Capital Flow
1
CCM
Cadian Capital Management
New York
+$8.9M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$5.23M
3
BlackRock
BlackRock
New York
+$3.66M
4
Macquarie Group
Macquarie Group
Australia
+$2.99M
5
Millennium Management
Millennium Management
New York
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$7.99M
2
GTC
Ghost Tree Capital
New York
-$3.77M
3
PVI
Pura Vida Investments
New York
-$2.01M
4
HCMT
Highland Capital Management (Texas)
Texas
-$1.69M
5
TAM
Tocqueville Asset Management
New York
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.31M +$392K +39,656 +61%
GIP
27
Granite Investment Partners
California
$994K +$785K +79,399 New
MCM
28
Moore Capital Management
New York
$938K -$247K -25,000 -25%
Deutsche Bank
29
Deutsche Bank
Germany
$801K +$317K +32,083 +100%
NC
30
NBW Capital
Massachusetts
$766K -$8.14K -824 -1%
TCIM
31
TIAA CREF Investment Management
New York
$765K +$185K +18,691 +44%
TA
32
Teachers Advisors
New York
$745K +$293K +29,617 +99%
Citadel Advisors
33
Citadel Advisors
Florida
$630K -$193K -19,547 -28%
Goldman Sachs
34
Goldman Sachs
New York
$604K -$169K -17,067 -26%
Charles Schwab
35
Charles Schwab
California
$564K – – –
SSA
36
Schonfeld Strategic Advisors
New York
$537K +$251K +25,425 +145%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$503K +$70.2K +7,100 +21%
Wells Fargo
38
Wells Fargo
California
$502K -$461K -46,658 -54%
HCM
39
Highbridge Capital Management
New York
$434K -$142K -14,387 -29%
BFS
40
Bradley Foster & Sargent
Connecticut
$403K +$318K +32,185 New
Swiss National Bank
41
Swiss National Bank
Switzerland
$379K – – –
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$365K +$32.5K +3,285 +13%
AllianceBernstein
43
AllianceBernstein
Tennessee
$345K +$119K +12,000 +77%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$343K +$96.1K +9,724 +55%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$303K +$84K +8,499 +54%
UBS Group
46
UBS Group
Switzerland
$267K +$74.5K +7,537 +55%
Commonwealth Equity Services
47
Commonwealth Equity Services
Massachusetts
$261K +$24.7K +2,499 +14%
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$233K +$51.1K +5,167 +38%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$225K +$178K +18,000 New
ProShare Advisors
50
ProShare Advisors
Maryland
$214K -$415 -42 -0.2%
1
2
3 4

COLL Hedge Fund Activity: Q2 2017 in Review

72 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2017, worth a combined $307M — up 31% from $235M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of COLL and 7 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 38 added.

The largest buyer was Cadian Capital Management, adding an estimated $8.9M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $7.99M sold.

  • 72 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2017, down from 83 in Q1 2017.
  • Funds reported $307M of Collegium Pharmaceutical stock for Q2 2017, up 31% quarter-over-quarter.
  • 7 funds opened new Collegium Pharmaceutical positions in Q2 2017 and 16 closed out, a net change of -9 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2017 was Cadian Capital Management, an estimated $8.9M added.
  • The largest Collegium Pharmaceutical seller in Q2 2017 was PFM Health Sciences, an estimated $7.99M sold.

Based on aggregated 13F filings for Q2 2017.